Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2016, Article ID 7041686, 4 pages
http://dx.doi.org/10.1155/2016/7041686
Case Report

A Successful Mother and Neonate Outcome for a Woman with Essential Thrombocytosis and FV Leiden Heterozygosity

1Blood Transfusion Department, Aretaieion Hospital, National and Kapodistrian Athens University Medical School, 11528 Athens, Greece
2Coagulation Laboratory, Iatriko Kentro Hospital, 11525 Athens, Greece
32nd Department of Obstetrics and Gynecology, Aretaieion Hospital, National and Kapodistrian Athens University Medical School, 11528 Athens, Greece

Received 3 December 2015; Revised 27 January 2016; Accepted 3 March 2016

Academic Editor: Dotun Ogunyemi

Copyright © 2016 Marianna Politou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Essential thrombocytosis (ET) and FV Leiden heterozygosity represent an acquired and hereditable hypercoagulable state, respectively. An uncommon case of coexistence of ET and FV Leiden heterozygosity in a 36-year-old pregnant woman and her successful pregnancy outcome is described. She was considered to be at high risk of thrombosis during her pregnancy and she was treated with both prophylactic dose of LMWH and aspirin daily throughout her pregnancy and for a 6-week period postpartum. The efficacy of the anticoagulation treatment was monitored in various time points not only by measuring anti-Xa levels and D-Dimers but also with new coagulation methods such as rotation thromboelastometry and multiplate. Global assessment of coagulation using additional newer laboratory tests might prove useful in monitoring coagulation pregnancies at high risk for thrombosis.